E28.0

Estrogen excess

Billable FY2026 2025-10-01 → 2026-09-30

Exclusions 5 never code together

E28code

Excludes1

Excludes1

Excludes1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 2

Use additional code

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)T36-T50 T36-T50

Notes

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8 E07.0 E16-E31 E34.-

Index entries leading here 5

Puberty (development state) Z00.3
- precocious (constitutional) (cryptogenic) (idiopathic) E30.1
  - due to
    - ovarian hyperfunction E28.1
      - estrogen E28.0
Excess, excessive, excessively
- estrogen E28.0
Hypersecretion
- estrogen E28.0
Increase, increased
- estrogen E28.0
Hyperestrogenism (drug-induced) (iatrogenic) E28.0

Alongside this code 5 same parent — E28

Additional references

AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

Present FY2024–FY2027.